NYSE, BIO - Bio-Rad Laboratories
Founded in 1952 and incorporated in 1957, Bio-Rad Laboratories, Inc. (referred
to in this report as ?Bio-Rad,? ?we,? ?us,? and ?our?) was initially engaged in
the development and produc?tion of specialty chemicals used in biochemical,
pharmaceutical and other life science research applications. In 1967, Bio-Rad
entered the field of clinical diagnostics with the development of its first test
kit based on separation techniques and materials developed for life science
research. Bio-Rad expanded into the field of analytical and measuring
instrument systems through internal research and development efforts and
acquisitions in the late 1970's and 1980's. In 1999, Bio-Rad acquired the stock
of Pasteur Sanofi Diagnostics and the rights to certain ancillary assets. This
strengthened our position in the HIV and infectious disease diagnostic product
market. In 2000 and 2004, Bio-Rad divested its semiconductor, optoelectronic
metrology and confocal microscopy product lines. ...
Read SEC Filing on NASDAQ.com »